(Q33387254)

26 July 2017

1 reference

title

Therapeutic apheresis: history, clinical application, and lingering uncertainties (English)

1 reference

26 July 2017

Bruce C McLeod

1

1 reference

26 July 2017

publication date

20 November 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

50

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

1413-1426

1 reference

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Plasma exchange in chronic progressive multiple sclerosis: a long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

THROMBOTIC THROMBOCYTOPENIC PURPURA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Treatment of Thrombotic Thrombocytopenic Purpura with Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02505.X

10.1111/J.1537-2995.2009.02505.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference